We observed a lower level of miR-206 in NAFLD and overexpression of miR-206 suppressed the excess accumulation of lipid by inhibiting the expression of lipogenesis-related proteins like SREBP1, FAS, SCD1, ACC1, and CD36. Here, FAS is linked to metabolic dysfunction-associated steatotic liver disease.